Prevalence and common genotypes of HCV infection in sudanese patients with hepatosplenic schistosomiasis

Journal of Medical Virology

Volumn 79, Issue 9, 2007, Pages 1322-1324

  Mudawi, H M Y ^a,c   Smith, H M ^b   Fletcher, I A ^b   Fedail, S S ^a  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NONE   (Sudan)

Author keywords

Hepatitis C virus; Hepatosplenic schistosomiasis; Parenteral antischistosomal therapy

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HEPATOSPLENIC SCHISTOSOMIASIS; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SCHISTOSOMIASIS; SEROPREVALENCE; SUDAN; VIRUS ISOLATION; VIRUS TRANSMISSION; VIRUS TYPING;

ADOLESCENT; ADULT; AGED; ANIMALS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER DISEASES, PARASITIC; MALE; MIDDLE AGED; PREVALENCE; SCHISTOSOMIASIS MANSONI; SEROEPIDEMIOLOGIC STUDIES; SPLENIC DISEASES; SUDAN;

HEPATITIS C VIRUS;

EID: 34547138659     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20865     Document Type: Article

References (24)

1. Abdel-Aziz F, Habib M, Mohamed MK, Abdel-Hamid M, Gamil F, Madkour S, Mikhail NN, Thomas D, Fix AD, Strickland GT, Anwar W, Sallam I. 2000. Hepatitis C virus (HCV) infection in a community in the Nile Delta: Population description and HCV prevalence. Hepatology 32:111-115.
2. Abdel-Wahab MF, Esmat G, Milad M, Abdel-Razek S, Strickland GT. 1989. Characteristic sonographic pattern of schistosomal hepatic fibrosis. Am J Trop Med Hyg 40:72-76.
3. al-Faleh FZ, Huraib S, Sbeih F, al-Karawi M, al-Rashed R, al-Mofleh IA, Sougiyyah M, Shaheen M, Ramia S. 1995. Hepatitis C virus genotypes in patients with chronic liver disease and haemodialysis patients from Saudi Arabia. J Viral Hepat 2:293-296.
4. Bassily S, Hyams KC, Fouad RA, Samaan MD, Hibbs RG. 1995. A high risk of hepatitis C infection among Egyptian blood donors: The role of parenteral drug abuse. Am J Trop Med Hyg 52:503-505.
5. Bayomi A. 1979. Schistosomiasis, the history of Sudan health services. Nairobi: Kenya Literature Bureau. p. 267-280.
6. Bruno S, Camma C, Di Marco V, Rumi M, Vinci M, Camozzi M, Rebucci C, Di Bona D, Colombo M, Craxi A, Mondelli MU, Pinzello G. 2004. Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: A randomized controlled trial. J Hepatol 41:474-481.
7. Bukh J, Miller RH, Purcell RH. 1995. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes. Semin Liver Dis 15:41-63.
8. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R. 1993. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 49:440-447.
9. el-Sayed NM, Gomatos PJ, Rodier GR, Wierzba TF, Darwish A, Khashaba S, Arthur RR. 1996. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: Association of hepatitis C virus infections with specific regions of Egypt. Am J Trop Med Hyg 55:179-184.
10. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891.
11. Fretz C, Jeannel D, Stuyver L, Herve V, Lunel F, Boudifa A, Mathiot C, de The G, Fournel JJ. 1995. HCV infection in a rural population of the Central African Republic (CAR): Evidence for three additional subtypes of genotype 4. J Med Virol 47:435-437.
12. Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H Jr, Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM. 2004. PEGASYS International Study Group. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose. Ann Intern Med 140:346-355.
13. Homeida M, Abdel-Gadir AF, Cheever AW, Bennett JL, Arbab BM, Ibrahium SZ, Abdel-Salam IM, Dafalla AA, Nash TE. 1988. Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: A prospective blinded study. Am J Trop Med Hyg 38:86-91.
14. Hoofnagle JH. 2002. Course and outcome of hepatitis C. Hepatology 36:S21-S29.
15. Kamal SM, El Tawil AA, Nakano T, He Q, Rasenack J, Hakam SA, Saleh WA, Ismail A, Aziz AA, Madwar MA. 2005. Peginterferon {alpha}-2b and ribavirin therapy in chronic hepatitis C genotype 4: Impact of treatment duration and viral kinetics on sustained virological response. Gut 54:858-866.
16. Lau JY, Davis GL, Prescott LE, Maertens G, Lindsay KL, Qian K, Mizokami M, Simmonds P. 1996. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 124:868-876.
17. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345:41-52.
18. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 358:958-965.
19. McCarthy MC, el-Tigani A, Khalid IO, Hyams KC. 1994. Hepatitis B and C in Juba, southern Sudan: Results of a serosurvey. Trans R Soc Trop Med Hyg 88:534-536.
20. Mohamed MK, Magder LS, Abdel-Hamid M, El-Daly M, Mikhail NN, Abdel-Aziz F, Medhat A, Thiers V, Strickland GT. 2006. Transmission of hepatitis C virus between parents and children. Am J Trop Med Hyg 75:16.
21. Njouom R, Pasquier C, Ayouba A, Gessain A, Froment A, Mfoupouendoun J, Pouillot R, Dubois M, Sandres-Saune K, Thonnon J, Izopet J, Nerrienet E. 2003. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J Med Virol 71:219-225.
22. Omer RE, Van't Veer P, Kadaru AM, Kampman E, el Khidir IM, Fedail SS, Kok FJ. 2001. The role of hepatitis B and hepatitis C viral infections in the incidence of hepatocellular carcinoma in Sudan. Trans R Soc Trop Med Hyg 95:487-491.
23. Oni AO, Harrison TJ. 1996. Genotypes of hepatitis C virus in Nigeria. J Med Virol 49:178-186.
24. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. 2000. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182:698-707.